Dexlansoprazole
- Product NDC
- 24979-704
- 11-digit product format
- 249790704
- Labeler code
- 24979
- Product ID
- 24979-704_14535d19-cc1d-4a41-96f1-cc5ff1660029
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dexlansoprazole
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- TWI PHARMACEUTICALS, INC.
- Application
- NDA022287
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2022-01-01
- Marketing end
- 0000-00-00
- Substance
- DEXLANSOPRAZOLE
- Active strength
- 60 mg/1
- Pharmacologic classes
- Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 24979-704-06 | Dexlansoprazole delayed release | 30 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 30 | | 4 |
| 24979-704-07 | Dexlansoprazole delayed release | 90 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 90 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 24979-704 | DEXLANSOPRAZOLE DELAYED RELEASE (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TWI PHARMACEUTICALS, INC.] | 4 | Legacy NDC, 2 package rows | 20230817_9abcfb1e-c894-44bb-807a-e4bdd755f28f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 24979-704-06 | 24979070406 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24979-704-06) | 2022-01-01 | 0000-00-00 | No | No | Current |
| 24979-704-07 | 24979070407 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24979-704-07) | 2022-01-01 | 0000-00-00 | No | No | Current |